Immunohistochemical staining of tumors showed that 25HC had no inhibitory effect on proliferation of lung cancer (PCNA, whereas 25HC plus gilteritinib reduced the number of PCNA-positive cells (Fig. 7D). The gene discussed is PCNA; the disease is lung carcinoma.